ENCANA CORP
Energy · Crude Petroleum & Natural Gas · A0 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|
| Revenue | $5.46B | $3.89B | $3.12B | $4.42B | $8.02B |
| Operating income | $337.0M | $489.0M | −$1.88B | −$6.30B | $2.33B |
| Net income | $151.0M | $431.0M | −$944.0M | −$5.17B | $3.39B |
| Total assets | $15.34B | $15.27B | $14.65B | $15.61B | — |
| Total liabilities | $7.90B | $8.54B | $8.53B | $9.45B | — |
| Equity | $7.45B | $6.73B | $6.13B | $6.17B | $9.69B |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 973.1M | 973.1M | 973.0M | 849.8M | 741.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- 6.2%
- Net margin
- 2.8%
- Return on equity
- 2.0%
- Return on assets
- 1.0%
- Return on capital (ROCE)
- 2.5%
- Liabilities / assets
- 51.5%
- Debt / equity
- 1.06×
- Book value / share
- $7.65
- Revenue growth (YoY)
- 40.2%
- Net income growth (YoY)
- −65.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- 1.51grey zone
- Accruals / assets
- −14.0%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 4 good- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Code Corey DouglasOfficer — EVP & CFO | Nov 29, 2019 | Buy | 10,000 | $3.95 |
| Mckenzie Margaret AnneDirector | Nov 12, 2019 | Buy | 12,000 | $4.52 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Other material eventJan 17, 2020
- Other material eventJan 16, 2020
- Shareholder vote · Other material eventJan 14, 2020
- Other material eventDec 11, 2019
- Other material eventNov 29, 2019
- Other material eventNov 20, 2019
- Other material eventNov 6, 2019
- Entered a material agreementNov 5, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G/AFeb 14, 2020
- SC 13G/ASCHEDULE 13G AMENDMENT 1Feb 7, 2020
- 15-12BFeb 6, 2020
- SC 13G/ASEC SCHEDULE 13GJan 27, 2020
- 25-NSEJan 27, 2020
- S-8 POSJan 27, 2020
- S-8 POSJan 27, 2020
- S-8 POSJan 27, 2020
- S-8 POSJan 27, 2020
- S-8 POSJan 27, 2020
- 8-KJan 17, 2020
- 8-KJan 16, 2020
- 8-KJan 14, 2020
- 425Dec 18, 2019
- 425Dec 17, 2019